Brachial-radial Pressure Gradient Phenomenon in Critically Ill Patients Treated With Vasoactive Agents

NCT ID: NCT07061457

Last Updated: 2025-11-20

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

300 participants

Study Classification

OBSERVATIONAL

Study Start Date

2025-04-14

Study Completion Date

2025-08-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The goal of this observational study is to observe brachial-to-radial pressure gradient in critically-ill patients receiving vasoactive agents. The main questions it aims to answer are:

1. What is the frequency of brachial-to-radial gradient in critically-ill patients receiving vasoactive agents?
2. Is brachial-to-radial gradient greater in patients receiving high doses of vasoactive agents?
3. Is brachial-to-radial gradient associated with worse peripheral perfusion?

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Pathological conditions, such as arterial stenosis, use of vasoconstrictive drugs, or massive vasodilatation, can cause significant differences in mean arterial pressure (MAP) in different parts of the arterial system. For example, in the case of stenosis between the brachial and radial arteries, the pressure behind the stenosis is lower than in front of it, which can lead to erroneous conclusions about the actual arterial pressure. The use of vasoconstrictive drugs in patients with circulatory insufficiency can result in reduced peripheral arterial pressure transmission, as evidenced by studies showing lower pressures in the radial artery compared to the femoral artery. Inadequate MAP assessments can lead to excessive use of vasoactive drugs and fluids, increasing the risk of complications such as cardiac ischemia, atrial fibrillation, and renal failure. One method to detect a significant gradient between central MAP (e.g., aorta or femoral artery) and peripheral MAP is non-invasive, oscillometric measurement of MAP on the brachial artery and comparing it to MAP obtained from invasive radial access (known as NIBR-APG). The brachial-radial MAP gradient is highly correlated with the femoral-radial gradient and may be indicative of significantly higher central pressure. The aim of this project is to evaluate the frequency of the brachial-radial gradient phenomenon in patients undergoing vasoconstrictive treatment in intensive care units.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Circulatory Failure Shock Vasopressor Agents Blood Pressure

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Adult critically-ill patients receiving vasoactive agents

Adult critically-ill patients receiving vasoactive agents and undergoing invasive blood pressure monitoring in the radial artery

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* adult (\>18 years) patients admitted to the ICU
* must be after initial resuscitation
* invasive blood pressure monitoring in the radial artery
* need for vasoactive drug therapy

Exclusion Criteria

* pregnancy
* pressure transduction across invasive blood pressure circuit deemed to be inadequate
* mechanical circulatory support
* inability to match non-invasive cuff size to the patient's arm
* need for any hemodynamic intervention during performing study's measurements
* patient's decline to have the measurements done
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Jagiellonian University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Wojciech Szczeklik

Professor

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Zbigniew Putowski, MD PhD

Role: STUDY_CHAIR

Center for Intensive Care and Perioperative Medicine, Jagiellonian University Medical College, Cracow, Poland

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

5 Szpital Wojskowy z PoliklinikÄ… w Krakowie

Krakow, , Poland

Site Status

Uniwersytecki Szpital w Opolu

Opole, , Poland

Site Status

Uniwersyteckie Centrum Kliniczne w Warszawie

Warsaw, , Poland

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Poland

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

118.0043.1.305.2024

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Blood Pressure Reduction in Heart Failure
NCT01255475 COMPLETED PHASE2/PHASE3
Simvastatin Effect on Portal Hypertension
NCT02134626 COMPLETED PHASE3